Mesothelioma Lawyers San Diego, Find a Mesothelioma Cancer Lawyer

Rosetta Genomics Announces Publication of Study on MicroRNA Expression for Lung Tumor Classification
REHOVOT, Israel & PHILADELPHIA—-Rosetta Genomics, Ltd. , a leading developer and provider of microRNA-based molecular diagnostic tests, announces the publication of a study showing microRNA expression differentiates between primary lung tumors and metastases to the lung.
Mesothelioma Lawyer, Asbestos Attorney – Lawsuit Litigation

Related Sites